{"schema_version":"secwatch.filing_event.v1","accession":"0001645113-24-000015","form_type":"8-K","ticker":"NVCR","cik":"0001645113","company_name":"NovoCure Ltd","filed_at":"2024-05-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.404965+00:00","generated_at":"2026-06-01T12:53:13.850147+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"NovoCure's METIS phase 3 trial data in brain metastases to be presented at ASCO 2024","bullets":["Abstract for METIS phase 3 trial in brain metastases from NSCLC available May 23 on ASCO website.","Oral presentation scheduled for June 3 at 10:24 AM CDT during CNS Tumors session.","No data disclosed yet; trial results are pending presentation at ASCO."],"urls":{"canonical":"https://secwatch.observer/filing/0001645113-24-000015","json":"https://secwatch.observer/filing/0001645113-24-000015.json","markdown":"https://secwatch.observer/filing/0001645113-24-000015.md","text":"https://secwatch.observer/filing/0001645113-24-000015.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1645113/000164511324000015/0001645113-24-000015-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1645113/000164511324000015/nvcr-20240520.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T12:53:13.850147+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}